anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
Compass Therapeutics | Investor Presentation Deck | 40 slides · page 24 of 40

The slide outlines a 2:1 randomized clinical trial structure for a drug combination (CTX-009 + Paclitaxel) versus a control (Paclitaxel).

Pitch deck · appendix_methodology · plan_implementation · balanced density

Deck inventory Unlock
More
Slide JSON Deck JSON
Slide locked Sign in to view
Slide schematic 3/3
diagram 1/1 paragraph 1/1 title 1/1
Components 3
process paragraph headline
Tools 1
Process flow slide · 80%

Flowchart showing 2:1 randomization into two arms, followed by 28-day treatment cycles, disease progression assessment, and study exit.
Metrics 0
∅
No metrics

No metric insight is anchored to this slide.

Frameworks 1
clinical-trial-design 90%

Standardized representation of patient randomization and treatment arms in clinical research.